Effect of Lactobacillus rhamnosus GG administration on vancomycin-resistant Enterococcus colonization in adults with comorbidities

Antimicrobial Agents and Chemotherapy

Volumn 59, Issue 8, 2015, Pages 4593-4599

  Doron, Shira ^a   Hibberd, Patricia L ^b   Goldin, Barry ^c   Thorpe, Cheleste ^a   McDermott, Laura ^a   Snydman, David R ^a  

^a TUFTS MEDICAL CENTER   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROBIOTIC AGENT; VANCOMYCIN;

AGED; BACTERIAL COUNT; CLINICAL TRIAL; COMORBIDITY; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FECES; FEMALE; GASTROINTESTINAL TRACT; GROWTH, DEVELOPMENT AND AGING; HUMAN; LACTOBACILLUS RHAMNOSUS; MALE; MICROBIOLOGY; MIDDLE AGED; RANDOMIZED CONTROLLED TRIAL; VANCOMYCIN RESISTANT ENTEROCOCCUS; VERY ELDERLY;

AGED; AGED, 80 AND OVER; COLONY COUNT, MICROBIAL; COMORBIDITY; DOUBLE-BLIND METHOD; FECES; FEMALE; GASTROINTESTINAL TRACT; HUMANS; LACTOBACILLUS RHAMNOSUS; MALE; MIDDLE AGED; PROBIOTICS; VANCOMYCIN; VANCOMYCIN-RESISTANT ENTEROCOCCI;

EID: 84939863732     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00300-15     Document Type: Article

References (24)

1. Murray BE. 2000. Vancomycin-resistant enterococcal infections. N Engl J Med 342:710-721. http://dx.doi.org/10.1056/NEJM200003093421007.
2. Montecalvo MA, de Lencastre H, Carraher M, Gedris C, Chung M, VanHorn K, Wormser GP. 1995. Natural history of colonization with vancomycin-resistant Enterococcus faecium. Infect Control Hosp Epidemiol 16:680-685. http://dx.doi.org/10.1086/647041.
3. Vergis EN, Hayden MK, Chow JW, Snydman DR, Zervos MJ, Linden PK, Wagener MM, Schmitt B, Muder RR. 2001. Determinants of vancomycin resistance and mortality rates in enterococcal bacteremia: a prospective multicenter study. Ann Intern Med 135:484-492. http://dx.doi.org/10.7326/0003-4819-135-7-200110020-00007.
4. Gorbach SL. 1996. The discovery of Lactobacillus GG. Nutr Today 31:25-45.
5. Salminen S, von Wright A, Morelli L, Marteau P, Brassart D, de Vos WM, Fondén R, Saxelin M, Collins K, Mogensen G. 1998. Demonstration of safety of probiotics: a review. Int J Food Microbiol 44:93-106. http://dx.doi.org/10.1016/S0168-1605(98)00128-7.
6. Pant AR, Graham SM, Allen SJ, Harikul S, Sabchareon A, Cuevas L, Hart CA. 1996. Lactobacillus GG and acute diarrhoea in young children in the tropics. J Trop Pediatr 42:162-165. http://dx.doi.org/10.1093/tropej/42.3.162.
7. Raza S, Graham SM, Allen SJ, Sultana S, Cuevas L, Hart CA. 1995. Lactobacillus GG promotes recovery from acute nonbloody diarrhea in Pakistan. Pediatr Infect Dis J 14:107-111. http://dx.doi.org/10.1097/00006454-199502000-00005.
8. Gorbach SL, Chang T-W, Goldin B. 1987. Successful treatment of relapsing Clostridium difficile colitis with Lactobacillus GG. Lancet 2:1519.
9. Oksanen PJ, Salminen S, Salexin M, Hamalainen P, Ihantola-Vormisto A, Muurasniemi-Isoviita L, Nikkari S, Oksanen T, Porsti T, Salminen E, Siitonen S, Stuckey H, Toppila A, Vapaatalo H. 1990. Prevention of traveler's diarrhoea by Lactobacillus GG. Ann Med 22:53-56. http://dx.doi.org/10.3109/07853899009147242.
10. Hilton E, Kolakowski P, Singer C, Smith M. 1997. Efficacy of Lactobacillus GG as a diarrheal preventive in travelers. J Travel Med 4:41-43. http://dx.doi.org/10.1111/j.1708-8305.1997.tb00772.x.
11. Salminen SJ, Donohue DC. 1996. Safety assessment of Lactobacillus strain GG (ATCC 53103). Nutr Today Suppl 31:12S-15S. http://dx.doi.org/10.1097/00017285-199611001-00004.
12. Salminen MK, Tynkkynen S, Rautelin H, Vaara M, Ruutu P, Sarna S, Valtonen V, Järvinen A. 2002. Lactobacillus bacteremia during a rapid increase in probiotic use of Lactobacillus rhamnosus GG in Finland. Clin Infect Dis 35:1155-1160. http://dx.doi.org/10.1086/342912.
13. Sullivan A, Nord CE. 2006. Probiotic lactobacilli and bacteraemia in Stockholm. Scand J Infect Dis 38:327-331. http://dx.doi.org/10.1080/00365540500449826.
14. Bayer AS, Chow AW, Ishida K, Morrison JO, Guze LB. 1981. Therapy of experimental infective endocarditis due to antibiotic-tolerant Lactobacillus plantarum-bactericidal synergy of penicillin plus gentamicin. Correlation of in vitro susceptibility studies with in vivo efficacy. Chemotherapy 27:444-451.
15. DeMan J, Rogosa C, Sharpe E. 1960. A medium for the cultivation of lactobacilli. J Appl Bacteriol 23:130-135. http://dx.doi.org/10.1111/j.1365-2672.1960.tb00188.x.
16. Sahm DF, Free L, Smith C, Eveland M, Mundy LM. 1997. Rapid characterization schemes for surveillance isolates of vancomycin-resistant enterococci. J Clin Microbiol 35:2026-2030.
17. Goldin BR, Gorbach SL, Saxelin M, Barakat S, Gualtieri L, Salminen S. 1992. Survival of Lactobacillus species (strain GG) in human gastrointestinal tract. Dig Dis Sci 37:121-128. http://dx.doi.org/10.1007/BF01308354.
18. Clinical and Laboratory Standards Institute. 2009. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard, 9th ed. CLSI publication number M07-A8. Clinical and Laboratory Standards Institute, Wayne, PA.
19. Ahlroos T, Tynkkynen S. 2009. Quantitative strain-specific detection of Lactobacillus rhamnosus GG in human faecal samples by real-time PCR. J Appl Microbiol 106:506-514. http://dx.doi.org/10.1111/j.1365-2672.2008.04018.x.
20. Manley KJ, Fraenkel MB, Mayall BC, Power DA. 2007. Probiotic treatment of vancomycin-resistant enterococci: a randomized controlled trial. Med J Aust 186:454-457.
21. Szachta P, Ignys I, Cichy W. 2011. An evaluation of the ability of the probiotic strain Lactobacillus rhamnosus GG to eliminate the gastrointestinal carrier state of vancomycin-resistant enterococci in colonized children. J Clin Gastroenterol 45:872-877. http://dx.doi.org/10.1097/MCG.0b013e318227439f.
22. Vidal M, Forestier C, Charbonnel N, Henard S, Rabaud C, Lesens O. 2010. Probiotics and intestinal colonization by vancomycin-resistant enterococci in mice and humans. J Clin Microbiol 48:2595-2598. http://dx.doi.org/10.1128/JCM.00473-10.
23. Hempel S, Newberry S, Ruelaz A, Wang Z, Miles J, Suttorp M, Johnsen B, Fu N, Smith A, Roth E, Polak J, Motala A, Shekelle PG. 2011. Safety of probiotics used to reduce risk and prevent or treat disease. Report/technology assessment no. 200. AHRQ publication no. 11-E007. Agency for Healthcare Research and Quality, Rockville, MD.
24. Wan LY, Chen ZJ, Shah NP, El-Nezami H. 28 January 2015. Modulation of intestinal epithelial defense responses by probiotic bacteria. Crit Rev Food Sci Nutr http://dx.doi.org/10.1080/10408398.2014.905450.